An Emerging Viral Infection in Horses in Central Europe: Suspected Shamonda Virus Seroconversion in Asymptomatic Horses in Baden-Württemberg from June to September 2026
Petra Benz
,Nathalie Hafner
,Marielle Elen Volkwein
,Judith Köster
,Thomas Miller
,Irena Blaha
Posted: 30 October 2026
The Kinematic Profile of the Marcha Batida Gait Is Distinct from the Marcha Picada Gait
Felipe César Álvares Santos
,Adalgiza Souza Carneiro Rezende
,Andressa Batista da Silveira Xavier
,Ângela Maria Quintão Lana
,Raphael Rocha Wenceslau
,Amaranta Sanches Gontijo
,Henrique Poppius Cruz
,Helena Sasdelli Miranda
,Matheus Camilo Vicente Santos
,Pedro Machado de Fátima
+2 authors
Posted: 21 October 2026
Phenotypic and Genotypic Characterization of Staphylococcus spp. Isolated from Cows with Clinical and Subclinical Mastitis in Kazakhstan
Lyailya Bessembayeva
,Zhumagul Kirkimbayeva
,Gulnur Kuzembekova
,Arman Zhylkaidar
,Assel Zholdasbekova
,Svetlana Yermagambetova
Posted: 13 October 2026
Alcaligenes faecalis A12C Modulates Hepatic and Renal Injury Response Associated with Sepsis: Experimental Study In Vivo
Rafael Alayón-Afonso
,Carlos José Martel-Benitez
,Gabriel Escarrer-Garau
,Ruth Henríquez-Cabrera
,Josep Mercader-Barceló
,Antonio Espinosa de Los Monteros y Zayas
,Daniel F. Padilla Castillo
,Fernando Real Valcárcel
,José Luis Martín-Barrasa
Sepsis is characterized by a dysregulated host response to infection; this can lead to multiorgan dysfunction where liver and kidneys play a key role. This study evaluated whether long-term oral administration of A12C modulates hepatic and renal homeostasis under basal conditions and during polymicrobial sepsis. Forty-five male Sprague–Dawley rats were allocated to healthy control (SAN), healthy A12C-treated (STO), septic control (IC), or septic A12C-treated (IA) groups. A12C was administered in drinking water at 6×108 CFU/mL for 30 days, and sepsis was induced by caecal ligation and puncture (CLP). Gene expression, protein abundance, antioxidant enzyme activities, and histopathological alterations were evaluated in liver and kidney. Under basal conditions, A12C reduced hepatic Tlr4 and Tgfb1 expression and TLR4, ICAM-1, and SOD2 protein abundance, whereas renal Tnf and Icam1 expression and SOD and GRd activities increased. During sepsis, A12C-treated rats showed lower hepatic expression of Tnf, Il6, Ccl2, Icam1, and Nos2, together with increased SOD1 protein abundance. In kidney, A12C reduced Tlr4, Il6 and Icam1 expression and increase CAT, GPx, and GRd activities. Reduced expression of several inflammatory and endothelial mediators was detected in both organs and a marked enhancement of renal antioxidant defences during sepsis. The present results support the potential of A12C to improve the host response to sepsis and limit sepsis-associated organ dysfunction, possibly through a preconditioning-like mechanism.
Sepsis is characterized by a dysregulated host response to infection; this can lead to multiorgan dysfunction where liver and kidneys play a key role. This study evaluated whether long-term oral administration of A12C modulates hepatic and renal homeostasis under basal conditions and during polymicrobial sepsis. Forty-five male Sprague–Dawley rats were allocated to healthy control (SAN), healthy A12C-treated (STO), septic control (IC), or septic A12C-treated (IA) groups. A12C was administered in drinking water at 6×108 CFU/mL for 30 days, and sepsis was induced by caecal ligation and puncture (CLP). Gene expression, protein abundance, antioxidant enzyme activities, and histopathological alterations were evaluated in liver and kidney. Under basal conditions, A12C reduced hepatic Tlr4 and Tgfb1 expression and TLR4, ICAM-1, and SOD2 protein abundance, whereas renal Tnf and Icam1 expression and SOD and GRd activities increased. During sepsis, A12C-treated rats showed lower hepatic expression of Tnf, Il6, Ccl2, Icam1, and Nos2, together with increased SOD1 protein abundance. In kidney, A12C reduced Tlr4, Il6 and Icam1 expression and increase CAT, GPx, and GRd activities. Reduced expression of several inflammatory and endothelial mediators was detected in both organs and a marked enhancement of renal antioxidant defences during sepsis. The present results support the potential of A12C to improve the host response to sepsis and limit sepsis-associated organ dysfunction, possibly through a preconditioning-like mechanism.
Posted: 13 October 2026
Multidrug-Resistant Bacteria in Small-Animal Veterinary Healthcare Settings: Mapping the Evidence on Bacterial Contamination, Antimicrobial Resistance, and Detection Sites
Marios Lysitsas
,Irene Chatzipanagiotidou
,George Valiakos
Posted: 10 October 2026
Maceration Time Modulates the In Vitro Antibacterial Activity of Ethanolic Dandelion (Taraxacum officinale) Extracts Against Escherichia coli and Staphylococcus aureus Isolates from Clinical Bovine Mastitis, with GC–MS Profiling of the Most Active Extract
Favian Bayas Morejón
,Ramón Espinoza Fernando
,Juan Gaibor Chávez
,Nancy Yolanda Galeas Paredes
,Alba Roxana Pilcolema Arteaga
,Orlando Meneses Quelal
Posted: 09 October 2026
Rethinking Feline Infectious Peritonitis Diagnosis: The FIP Predictive Score Within an Effusion-Based Diagnostic Algorithm – A Pilot Study
Filipe Sampaio
,Hugo Lima de Carvalho
,Gonçalo Barros
,Inês Borges
,Cátia Fernandes
,Cristina Costa Santos
,Ricardo Lopes
Posted: 09 October 2026
Case Report: Detection of Shamonda Virus in Two Horses with Neurological Signs in Germany
Marielle Volkwein
,Judith Köster
,Ernst Großmann
,Nathalie Hafner
,Thomas Miller
,Andreas Salditt
,Petra Benz
,Martin Beer
,Angele Breithaupt
,Kerstin Wernike
Posted: 09 October 2026
From Effusion to Diagnosis: Integrating the FIP Effusion Index and Cell Tube Block Immunohistochemistry in a Geriatric Cat
Ricardo Lopes
,Cátia Fernandes
,Hugo Lima de Carvalho
,Gonçalo Barros
,Filipe Sampaio
Posted: 08 October 2026
Comparative Histopathology of Yellow Fever in New and Old World Non-Human Primates: Hepatic and Extrahepatic Lesions in Susceptible Species
D. Katterine Bonilla-Aldana
,Jorge Luis Bonilla-Aldana
,Ivan Camilo Sanchez-Rojas
,Lysien I. Zambrano
,Alberto E. Paniz-Mondolfi
,Alfonso J. Rodríguez-Morales
Posted: 07 October 2026
Inhibitory Effect of Carvacrol on Horizontal Transfer of the optrA-Carrying Pheromone-Responsive Conjugative Plasmid in Porcine Enterococcus faecalis
Xinxin Shan
,Jingwei Xue
,Bangwei Shi
,Weihang Yun
,Chen Yang Cao
,Di Wu
,Lin Li
Posted: 06 October 2026
First Detection of Amdoparvovirus carnivoran3 in a Clinically Ill Domestic Dog in Croatia, with Retrospective Molecular Screening
Ivona Ćorić
,Gorana Miletić
,Andrea Gudan Kurilj
,Ljubo Barbić
,Snježana Kovač
,Alenka Škrinjarić
,Marija Batinjan Matković
,Zvonimir Pavlović
,Iva Zečević
,Iva Benvin
+1 authors
Posted: 30 September 2026
Acute Phase Proteins in Bovine Mastitis: Emerging Biomarkers Linking Udder Inflammation, Milk Quality and Residues Risk
Konstantinos V. Arsenopoulos
,Ioannis K. Karabagias
,Manos C. Vlasiou
Posted: 25 September 2026
Ehrlichia spp. and Ehrlichioses: Diversity, Distribution, Zoonotic Potential, and Challenges for Surveillance from a One Health Perspective
Aline Kelly Velame Ferreira
,Juan Dario Puentes Santisteban
,Franklin Riet-Correa
,Beatriz do Nascimento Beserra
,Carla Alves Rabello
,Vânia Rita Elias Pinheiro Bittencourt
,Isabele da Costa Angelo
,Patrícia Silva Golo
,Huarrisson Azevedo Santos
,Tiago Marques Santos
+2 authors
Posted: 23 September 2026
Short-Term Effects of Meloxicam and Marine-Based Fatty Acid Compounds on Objective Limb Loading and Owner-Reported Outcomes in Dogs with Hip Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
Narudee Kashemsant
,Panida Panitsillapakit
,Monchanok Vijarnsorn
,Chalermpol Lekcharoensuk
,Sarawut Yangtara
,Julaporn Pooliam
,B. Duncan X. Lascelles
Posted: 20 September 2026
Antibacterial and Anti-Biofilm Activities of Essential Oils Against Etiological Agents of Bovine Mastitis
Alice Caneschi
,Donatella Scarafile
,Monica Modesto
,Maurizio Scozzoli
,Paola Mattarelli
,Anna Zaghini
Background: The inflammation of the mammary gland, known as bovine mastitis, is a major challenge for the dairy cattle industry globally. The main organisms responsible for mastitis are bacteria, classified as either contagious, such as Staphylococcus aureus, Streptococcus dysgalactiae, and Streptococcus agalactiae; or environmental, primarily Streptococcus spp. (e.g. Streptococcus uberis) and coliform species. Even though the emergence of antibiotic-resistant strains of pathogens poses a serious threat, antibiotics are still the primary treatment for mastitis. It is therefore necessary to explore alternative therapies, such as essential oils (EOs). This in vitro research intended to evaluate the efficacy of EOs against etiological agents of bovine mastitis, as an alternative or complementary treatment to conventional antibiotics. Methods: The bactericidal activity of eleven essential oils and two blends was tested on five strains causing bovine mastitis: Str. agalactiae, Str. dysgalactiae, Str. uberis, Sta. aureus, and Staphylococcus epidermidis. An assessment was carried out of both the reduction of biofilm formation and the inhibition of pre-formed biofilm against biofilm-formative strains of Sta. aureus and Sta. epidermitis. Results: Origanum vulgare and Cinnamomum zeylanicum resulted to be the EOs with the highest activity against the above-mentioned bacteria, inhibiting both bacterial growth and biofilm formation. Conclusions: This study emphasises the relevance of investigating natural products and supports the hypothesis of safe use of EOs to reduce bacterial infections and provide an effective alternative to antibiotics in complementary therapy. Moreover, to avoid treatment failure, the combined use of available antibiotics and natural compounds should also be considered.
Background: The inflammation of the mammary gland, known as bovine mastitis, is a major challenge for the dairy cattle industry globally. The main organisms responsible for mastitis are bacteria, classified as either contagious, such as Staphylococcus aureus, Streptococcus dysgalactiae, and Streptococcus agalactiae; or environmental, primarily Streptococcus spp. (e.g. Streptococcus uberis) and coliform species. Even though the emergence of antibiotic-resistant strains of pathogens poses a serious threat, antibiotics are still the primary treatment for mastitis. It is therefore necessary to explore alternative therapies, such as essential oils (EOs). This in vitro research intended to evaluate the efficacy of EOs against etiological agents of bovine mastitis, as an alternative or complementary treatment to conventional antibiotics. Methods: The bactericidal activity of eleven essential oils and two blends was tested on five strains causing bovine mastitis: Str. agalactiae, Str. dysgalactiae, Str. uberis, Sta. aureus, and Staphylococcus epidermidis. An assessment was carried out of both the reduction of biofilm formation and the inhibition of pre-formed biofilm against biofilm-formative strains of Sta. aureus and Sta. epidermitis. Results: Origanum vulgare and Cinnamomum zeylanicum resulted to be the EOs with the highest activity against the above-mentioned bacteria, inhibiting both bacterial growth and biofilm formation. Conclusions: This study emphasises the relevance of investigating natural products and supports the hypothesis of safe use of EOs to reduce bacterial infections and provide an effective alternative to antibiotics in complementary therapy. Moreover, to avoid treatment failure, the combined use of available antibiotics and natural compounds should also be considered.
Posted: 31 August 2026
Effects of Sample Matrix, RNA Extraction Method, Carrier RNA, and Storage Conditions on RT-qPCR Detection of Foot-and-Mouth Disease Virus
Vesna Milićević
,Bojan Milovanović
,Zorana Zurovac Sapundžić
,Sofija Šolaja
,Dimitrije Glišić
,Đorđe Aksić
,Ljubiša Veljović
,George Valiakos
Posted: 28 August 2026
Extended Reality for Image-Guided Small Animal Surgery: Current Evidence, Clinical Applications, and Future Directions
Domenico Caivano
,Federica Valeri
,Andrea Corda
,Antonello Bufalari
Posted: 26 August 2026
Hematologic and Renal Trends in Cats Undergoing Continuous Renal Replacement Therapy with Adjunctive Molidustat Administration: A Retrospective Case Series
Gippeum Lee
,Jeongmin Lee
,Kun-Ho Song
Continuous renal replacement therapy (CRRT) can precipitate anemia in critically ill patients, but temporal hematologic trends and anemia management strategies in cats remain poorly characterized. Medical records of three client-owned cats treated with CRRT for severe acute kidney injury with evidence of pre-existing chronic kidney disease at a single referral center were retrospectively reviewed. Hematologic variables (hematocrit, hemoglobin concentration, absolute reticulocyte count) and renal parameters (blood urea nitrogen, creatinine, phosphorus) were evaluated before, during, and after CRRT, along with the timing of CRRT sessions, whole blood transfusions, erythropoiesis-stimulating agent administration, and adjunctive molidustat use. All three cats demonstrated a progressive decline in hematocrit during the CRRT period despite repeated whole blood transfusions, with only transient post-transfusion improvement. Blood urea nitrogen and creatinine concentrations decreased promptly following CRRT initiation but showed variable rebound patterns during follow-up. Absolute reticulocyte counts increased after CRRT discontinuation in two cats, indicating preserved or recovering erythropoietic activity, while one cat with concurrent systemic inflammation showed a minimal response. Progressive anemia occurred consistently despite transfusion support, highlighting the multifactorial nature of anemia during feline CRRT. These descriptive findings provide clinically relevant insight into anemia progression during feline CRRT and may inform the design of future prospective studies.
Continuous renal replacement therapy (CRRT) can precipitate anemia in critically ill patients, but temporal hematologic trends and anemia management strategies in cats remain poorly characterized. Medical records of three client-owned cats treated with CRRT for severe acute kidney injury with evidence of pre-existing chronic kidney disease at a single referral center were retrospectively reviewed. Hematologic variables (hematocrit, hemoglobin concentration, absolute reticulocyte count) and renal parameters (blood urea nitrogen, creatinine, phosphorus) were evaluated before, during, and after CRRT, along with the timing of CRRT sessions, whole blood transfusions, erythropoiesis-stimulating agent administration, and adjunctive molidustat use. All three cats demonstrated a progressive decline in hematocrit during the CRRT period despite repeated whole blood transfusions, with only transient post-transfusion improvement. Blood urea nitrogen and creatinine concentrations decreased promptly following CRRT initiation but showed variable rebound patterns during follow-up. Absolute reticulocyte counts increased after CRRT discontinuation in two cats, indicating preserved or recovering erythropoietic activity, while one cat with concurrent systemic inflammation showed a minimal response. Progressive anemia occurred consistently despite transfusion support, highlighting the multifactorial nature of anemia during feline CRRT. These descriptive findings provide clinically relevant insight into anemia progression during feline CRRT and may inform the design of future prospective studies.
Posted: 17 August 2026
KLH-Based Multimodal Management of Clinically Diagnosed Canine Urothelial Carcinoma: A Two-Case Series
Ji-Hee Hong
,Jihyun Kim
,Kun-Ho Song
Posted: 05 August 2026
of 18